Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Novartis today announced positive topline results from APPULSEPNH a Phase IIIB study evaluating the efficacy and safety of twicedaily oral monotherapy Fabhalta iptacopan in adult patients with paroxysmal nocturnal hemoglobinuria PNH
Teva Pharmaceutical Industries Ltdannounced that it has entered into an agreement with JKI established by the fund managed and operated by JWill whereby all shares of Teva Takeda Pharma Limited and its wholly owned subsidiary Teva Takeda Yakuhin Ltd...
GSK plc today announced that it has entered into an agreement with Chongqing Zhifei Biological Products Ltd Zhifei to revise the terms on which Zhifei will commercialise GSKs shingles vaccine Shingrix in mainland China
Jazz Pharmaceuticals plc today announced that zanidatamabhrii Ziihera mgmL for injection for intravenous use is recommended by the National Comprehensive Cancer Network NCCN
Alamar Biosciences a company powering precision proteomics to enable the earliest detection of disease is proud to announce its commercial presence in the Asia Pacific APAC region with the installation of the ARGO HT System an advanced ultrasensitive...
Bioaerosols arent welcome in any laboratory They can consist of bacteria cell fragments fungal spores or viruses as well as byproducts of microbial metabolism Aerosols are easily generated in various concentrations during simple routine tasks in the...
ADVANZ PHARMA Holdco Limited a UK headquartered global pharmaceutical company with a strategic focus on speciality hospital and rare disease medicines today announced the expansion of its specialty brands portfolio with the acquisition of certain APA...
Cinclus Pharma a clinicalstage pharmaceutical company developing molecules for the treatment of gastric acidrelated diseases today announced that its leading drug candidate linaprazan glurate
Eisai Co Ltd and Biogen Inc Nasdaq BIIB Corporate headquarters Cambridge Massachusetts CEO Christopher A Viehbacher Biogen announced today that the Federal Commission for the Protection Against Sanitary Risk COFEPRIS
Matica Biotechnology a leading contract development and manufacturing organization CDMO specializing in viral vector development and manufacturing today announced a strategic partnerships with Treovir
